Platelet factor 4 mRNA expression in human erythroleukemic cells: regulation by phorbol esters and certain cytokines

Exp Hematol. 1991 Sep;19(8):779-84.

Abstract

Developing megakaryocytes are distinguished from progenitor cells by the appearance of platelet proteins such as platelet factor 4 (PF 4). The human erythroleukemic cell line HEL can also be induced to produce PF 4 by incubation in phorbol esters. HEL cells were used here as a model system in which to study the phenomenon of inducible PF 4 production at both the mRNA and protein levels. The cytokines interleukin 1 beta (IL-1 beta), interleukin 3 (IL-3), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF), erythropoietin (EPO), and transforming growth factor-beta (TGF-beta) were also evaluated for their effects on PF 4 mRNA induction in HEL cells.

MeSH terms

  • Antigens, Surface / analysis
  • Blood Platelets / immunology
  • Cell Line
  • Cycloheximide / pharmacology
  • Cytokines / pharmacology
  • DNA / biosynthesis
  • Gene Expression / drug effects
  • Humans
  • Leukemia, Erythroblastic, Acute / genetics*
  • Platelet Factor 4 / genetics*
  • Platelet Factor 4 / metabolism
  • Platelet Membrane Glycoproteins / immunology
  • Platelet Membrane Glycoproteins / metabolism
  • RNA, Messenger / genetics
  • RNA, Neoplasm / genetics
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Transforming Growth Factor beta / pharmacology*

Substances

  • Antigens, Surface
  • Cytokines
  • Platelet Membrane Glycoproteins
  • RNA, Messenger
  • RNA, Neoplasm
  • Transforming Growth Factor beta
  • Platelet Factor 4
  • DNA
  • Cycloheximide
  • Tetradecanoylphorbol Acetate